Prothena (PRTA) Competitors

Phibro Animal Health (NASDAQ:PAHC) and Prothena (NASDAQ:PRTA) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, valuation, earnings, dividends, risk, media sentiment, profitability, analyst recommendations and institutional ownership.

Does the media refer more to PAHC or PRTA?

In the previous week, Prothena had 7 more articles in the media than Phibro Animal Health. MarketBeat recorded 11 mentions for Prothena and 4 mentions for Phibro Animal Health. Phibro Animal Health's average media sentiment score of 1.23 beat Prothena's score of 0.89 indicating that Phibro Animal Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Phibro Animal Health	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Prothena	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk and volatility, PAHC or PRTA?

Phibro Animal Health has a beta of 0.74, suggesting that its share price is 26% less volatile than the S&P 500. Comparatively, Prothena has a beta of -0.08, suggesting that its share price is 108% less volatile than the S&P 500.

Which has stronger earnings & valuation, PAHC or PRTA?

Phibro Animal Health has higher revenue and earnings than Prothena. Prothena is trading at a lower price-to-earnings ratio than Phibro Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Phibro Animal Health	$1.19B	0.83	$2.42M	$0.78	31.12
Prothena	$137.94M	1.98	-$147.03M	-$2.08	-2.43

Do insiders and institutionals hold more shares of PAHC or PRTA?

99.3% of Phibro Animal Health shares are owned by institutional investors. Comparatively, 97.1% of Prothena shares are owned by institutional investors. 50.1% of Phibro Animal Health shares are owned by company insiders. Comparatively, 9.2% of Prothena shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Does the MarketBeat Community prefer PAHC or PRTA?

Prothena received 303 more outperform votes than Phibro Animal Health when rated by MarketBeat users. Likewise, 70.37% of users gave Prothena an outperform vote while only 59.81% of users gave Phibro Animal Health an outperform vote.

Company	Underperform	Outperform
Phibro Animal Health	Outperform Votes 317 59.81%	Underperform Votes 213 40.19%
Prothena	Outperform Votes 620 70.37%	Underperform Votes 261 29.63%

Do analysts prefer PAHC or PRTA?

Phibro Animal Health currently has a consensus target price of $20.00, suggesting a potential downside of 17.60%. Prothena has a consensus target price of $31.50, suggesting a potential upside of 522.28%. Given Prothena's stronger consensus rating and higher probable upside, analysts plainly believe Prothena is more favorable than Phibro Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Phibro Animal Health	2 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Prothena	1 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.33

Is PAHC or PRTA more profitable?

Phibro Animal Health has a net margin of 1.75% compared to Prothena's net margin of -90.50%. Phibro Animal Health's return on equity of 25.35% beat Prothena's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Phibro Animal Health	1.75%	25.35%	6.21%
Prothena	-90.50%	-22.67%	-19.68%

Summary

Phibro Animal Health beats Prothena on 11 of the 18 factors compared between the two stocks.